A etrospective study evaluated the response rates of 50 patients treated with Etoposide - Cisplatin (EP) regimen and 31 patients treated with Pemetrexed - Cisplatin (PeC) regimen concurrently with 3D radiation for inoperable stage III lung adenocarcinoma.